Third, although TKIs can effectively inhibit angiogenesis and tumor proliferation through the VEGF, PDGF, and fibroblast growth factor receptor pathways, tumor cells can develop adaptive resistance mechanisms through these pathways. Here, VEGFA is linked to neoplasm.